Imaging test to measure brain blood flow in stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies a new imaging measurement derived from DSA (a special type of brain blood-vessel scan) to better estimate how well blood is flowing in the brain. It may help doctors assess stroke-related blood-flow problems, but it excludes people who have brain bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of cerebral ischemia (reduced blood flow to the brain, such as ischemic stroke).
- You have already had DSA, a scan that looks at brain blood vessels using contrast dye and X-rays.
- You do not currently have cerebral hemorrhage (bleeding in the brain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that may help doctors see how blood flows in the brain after a stroke or mini-stroke. It could help guide treatment for people with severe narrowing in one of the main arteries in the neck or head.
This study uses a special computer platform to analyze DSA scan images from people with brain blood vessel diseases. It aims to better understand their condition and guide treatment decisions.
This study uses MRI and ultrasound to look closely at brain artery plaques that may release clots and cause stroke. It aims to better understand which plaque features signal higher “embolus” risk, which could guide future care.
This study measures blood flow in small areas of the brain to see if it can help detect cerebrovascular disease. It includes people recovering from a stroke and healthy volunteers, and may help improve future diagnosis.
This trial uses a special imaging technique to check if blood flow has fully returned to the brain after a stroke clot is removed. It aims to improve understanding of how well the brain's tiny blood vessels are working after treatment.
This study looks at a special scan (DSA, done with contrast dye) to find a likely “target” that doctors can use when treating sudden brain bleeding. It’s meant to help doctors better understand where treatment may be needed soon after symptoms start.
Hear when a new Cerebral Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.